HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudia Bronner Selected Research

2- (3- (2- aminoethyl)- 1H- indol- 5- yloxy)acetyl- L- tyrosyl- glycinamide (IS 159)

8/2014Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claudia Bronner Research Topics

Disease

1Neoplasms (Cancer)
08/2014
1Prostatic Neoplasms (Prostate Cancer)
08/2014

Drug/Important Bio-Agent (IBA)

12- (3- (2- aminoethyl)- 1H- indol- 5- yloxy)acetyl- L- tyrosyl- glycinamide (IS 159)IBA
08/2014
1Capsules (Microcapsules)IBA
08/2014
1Prostate-Specific Antigen (Semenogelase)IBA
08/2014

Therapy/Procedure

1Prostatectomy (Retropubic Prostatectomy)
08/2014
1Radiotherapy
08/2014